MCID: MLT138
MIFTS: 40

Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases, Skin diseases

Aliases & Classifications for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

MalaCards integrated aliases for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum:

Name: Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum 58
Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum Disorders 6
Nodulosis-Arthropathy-Osteolysis Syndrome 58
Torg-Winchester Syndrome 58
Mona Spectrum 58
Nao Syndrome 58

Characteristics:

Orphanet epidemiological data:

58
multicentric osteolysis-nodulosis-arthropathy spectrum
Inheritance: Autosomal recessive; Age of onset: Childhood,Infancy; Age of death: normal life expectancy;

Classifications:

Orphanet: 58  
Rare bone diseases
Developmental anomalies during embryogenesis


Summaries for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

MalaCards based summary : Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum, also known as multicentric osteolysis-nodulosis-arthropathy spectrum disorders, is related to multicentric osteolysis, nodulosis, and arthropathy and winchester syndrome. An important gene associated with Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum is MMP2 (Matrix Metallopeptidase 2), and among its related pathways/superpathways are Development Endothelin-1/EDNRA signaling and Colorectal Cancer Metastasis. The drugs Zoledronic Acid and Pamidronate have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and ovary, and related phenotypes are arthritis and abnormal facial shape

Related Diseases for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Graphical network of the top 20 diseases related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum:



Diseases related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Symptoms & Phenotypes for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Human phenotypes related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum:

58 31 (show all 39)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 arthritis 58 31 hallmark (90%) Very frequent (99-80%) HP:0001369
2 abnormal facial shape 58 31 hallmark (90%) Very frequent (99-80%) HP:0001999
3 osteopenia 58 31 hallmark (90%) Very frequent (99-80%) HP:0000938
4 osteoporosis 58 31 hallmark (90%) Very frequent (99-80%) HP:0000939
5 abnormal hand morphology 58 31 hallmark (90%) Very frequent (99-80%) HP:0005922
6 hirsutism 58 31 hallmark (90%) Very frequent (99-80%) HP:0001007
7 carpal osteolysis 58 31 hallmark (90%) Very frequent (99-80%) HP:0001495
8 arthropathy 58 31 hallmark (90%) Very frequent (99-80%) HP:0003040
9 osteolysis involving tarsal bones 58 31 hallmark (90%) Very frequent (99-80%) HP:0006234
10 brachycephaly 58 31 frequent (33%) Frequent (79-30%) HP:0000248
11 subcutaneous nodule 58 31 frequent (33%) Frequent (79-30%) HP:0001482
12 abnormal form of the vertebral bodies 58 31 frequent (33%) Frequent (79-30%) HP:0003312
13 broad clavicles 58 31 frequent (33%) Frequent (79-30%) HP:0000916
14 broad metacarpals 58 31 frequent (33%) Frequent (79-30%) HP:0001230
15 sclerotic cranial sutures 58 31 frequent (33%) Frequent (79-30%) HP:0005441
16 intellectual disability 58 31 occasional (7.5%) Occasional (29-5%) HP:0001249
17 type i diabetes mellitus 58 31 occasional (7.5%) Occasional (29-5%) HP:0100651
18 atrioventricular block 58 31 occasional (7.5%) Occasional (29-5%) HP:0001678
19 hypertension 58 31 occasional (7.5%) Occasional (29-5%) HP:0000822
20 atrial septal defect 58 31 occasional (7.5%) Occasional (29-5%) HP:0001631
21 bicuspid aortic valve 58 31 occasional (7.5%) Occasional (29-5%) HP:0001647
22 coarctation of aorta 58 31 occasional (7.5%) Occasional (29-5%) HP:0001680
23 mitral valve prolapse 58 31 occasional (7.5%) Occasional (29-5%) HP:0001634
24 polycystic ovaries 58 31 occasional (7.5%) Occasional (29-5%) HP:0000147
25 iris coloboma 58 31 occasional (7.5%) Occasional (29-5%) HP:0000612
26 ventricular septal defect 58 31 occasional (7.5%) Occasional (29-5%) HP:0001629
27 omphalocele 58 31 occasional (7.5%) Occasional (29-5%) HP:0001539
28 pterygium 58 31 occasional (7.5%) Occasional (29-5%) HP:0001059
29 increased susceptibility to fractures 58 31 occasional (7.5%) Occasional (29-5%) HP:0002659
30 papilledema 58 31 occasional (7.5%) Occasional (29-5%) HP:0001085
31 premature thelarche 58 31 occasional (7.5%) Occasional (29-5%) HP:0010314
32 nodular goiter 58 31 occasional (7.5%) Occasional (29-5%) HP:0005994
33 abnormality of the orbital region 58 31 occasional (7.5%) Occasional (29-5%) HP:0000315
34 double outlet right ventricle 58 31 occasional (7.5%) Occasional (29-5%) HP:0001719
35 abnormality of the cardiovascular system 58 Frequent (79-30%)
36 osteolysis 58 Very frequent (99-80%)
37 localized skin lesion 58 Frequent (79-30%)
38 osteolysis involving bones of the lower limbs 58 Very frequent (99-80%)
39 osteolysis involving bones of the upper limbs 58 Very frequent (99-80%)

Drugs & Therapeutics for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Drugs for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zoledronic Acid Approved 118072-93-8 68740
2
Pamidronate Approved 40391-99-9 4674
3 Diphosphonates

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Bisphosphonates in Multicentric Osteolysis, Nodulosis and Arthropathy (MONA) Spectrum Disorder - an Alternative Therapeutic Approach Completed NCT02823925 Pamidronate or Zoledronate

Search NIH Clinical Center for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Genetic Tests for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Anatomical Context for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

MalaCards organs/tissues related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum:

40
Bone, Skin, Ovary

Publications for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Articles related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum:

(show all 15)
# Title Authors PMID Year
1
Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome. 6 61
17059372 2007
2
Multicentric Osteolysis Nodulosis and Arthropathy 6
27413800 2016
3
Mutation of membrane type-1 metalloproteinase, MT1-MMP, causes the multicentric osteolysis and arthritis disease Winchester syndrome. 6
22922033 2012
4
A novel homozygous MMP2 mutation in a family with Winchester syndrome. 6
16542393 2006
5
Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. 6
15691365 2005
6
Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. 6
11431697 2001
7
Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. 6
10356396 1999
8
[Biochemical and ultrastructural study of two familial cases of Winchester syndrome]. 6
2625626 1989
9
An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. 6
6525336 1984
10
A new acid mucopolysaccharidosis with skeletal deformities simulating rheumatoid arthritis. 6
4238825 1969
11
Identification of drug-target interaction from interactome network with 'guilt-by-association' principle and topology features. 61
26614126 2016
12
A report of three patients with MMP2 associated hereditary osteolysis. 61
22876575 2012
13
A novel homozygous MMP2 mutation in a patient with Torg-Winchester syndrome. 61
20720557 2010
14
Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene. 61
19653001 2010
15
Torg-Winchester syndrome: lack of efficacy of pamidronate therapy. 61
17351352 2007

Variations for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

ClinVar genetic disease variations for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum:

6 (show top 50) (show all 102) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 LPCAT2 NM_017839.5(LPCAT2):c.172-6188G>ASNV Pathogenic 625853 rs1567390809 16:55553232-55553232 16:55519320-55519320
2 MMP2 NM_004530.6(MMP2):c.1648C>T (p.Arg550Ter)SNV Pathogenic 915430 16:55532239-55532239 16:55498327-55498327
3 MMP2 NM_004530.6(MMP2):c.302G>A (p.Arg101His)SNV Pathogenic 17108 rs121912953 16:55516969-55516969 16:55483057-55483057
4 MMP2 NM_004530.6(MMP2):c.732C>A (p.Tyr244Ter)SNV Pathogenic 17109 rs121912954 16:55519589-55519589 16:55485677-55485677
5 MMP2 NM_004530.6(MMP2):c.1210G>A (p.Glu404Lys)SNV Pathogenic 17110 rs121912955 16:55525742-55525742 16:55491830-55491830
6 MMP2 MMP2, 3-BP DEL, 1488TGGdeletion Pathogenic 17111
7 MMP2 NM_004530.6(MMP2):c.1357del (p.Gly454fs)deletion Pathogenic 17112 rs1567378779 16:55527089-55527089 16:55493177-55493177
8 MMP2 NM_004530.6(MMP2):c.1858G>A (p.Val620Ile)SNV Conflicting interpretations of pathogenicity 194059 rs41459945 16:55536779-55536779 16:55502867-55502867
9 MMP2 NM_004530.6(MMP2):c.759C>T (p.Ser253=)SNV Conflicting interpretations of pathogenicity 283518 rs148801200 16:55519616-55519616 16:55485704-55485704
10 MMP2 NM_004530.6(MMP2):c.658+10G>ASNV Conflicting interpretations of pathogenicity 319748 rs201653184 16:55519349-55519349 16:55485437-55485437
11 MMP2 NM_004530.6(MMP2):c.1860C>T (p.Val620=)SNV Conflicting interpretations of pathogenicity 714021 16:55536781-55536781 16:55502869-55502869
12 MMP2 NM_004530.6(MMP2):c.96G>T (p.Ser32=)SNV Conflicting interpretations of pathogenicity 729361 16:55513487-55513487 16:55479575-55479575
13 MMP2 NM_004530.6(MMP2):c.1842C>T (p.Pro614=)SNV Conflicting interpretations of pathogenicity 732303 16:55536763-55536763 16:55502851-55502851
14 MMP2 NM_004530.6(MMP2):c.1233G>A (p.Leu411=)SNV Conflicting interpretations of pathogenicity 319757 rs140172728 16:55525765-55525765 16:55491853-55491853
15 MMP2 NM_004530.6(MMP2):c.1572C>T (p.Tyr524=)SNV Conflicting interpretations of pathogenicity 319763 rs374801798 16:55530937-55530937 16:55497025-55497025
16 MMP2 NM_004530.6(MMP2):c.1758C>A (p.Asp586Glu)SNV Uncertain significance 319764 rs746772419 16:55532349-55532349 16:55498437-55498437
17 MMP2 NM_004530.6(MMP2):c.*51G>ASNV Uncertain significance 319770 rs200211639 16:55539405-55539405 16:55505493-55505493
18 MMP2 NM_004530.6(MMP2):c.*132T>ASNV Uncertain significance 319771 rs55926431 16:55539486-55539486 16:55505574-55505574
19 MMP2 NM_004530.6(MMP2):c.1336+11G>ASNV Uncertain significance 319758 rs17859933 16:55525879-55525879 16:55491967-55491967
20 MMP2 NM_004530.6(MMP2):c.*627T>CSNV Uncertain significance 319781 rs886052129 16:55539981-55539981 16:55506069-55506069
21 MMP2 NM_004530.6(MMP2):c.*930C>TSNV Uncertain significance 319785 rs886052130 16:55540284-55540284 16:55506372-55506372
22 MMP2 NM_004530.6(MMP2):c.-201C>GSNV Uncertain significance 319741 rs886052124 16:55513191-55513191 16:55479279-55479279
23 MMP2 NM_004530.6(MMP2):c.-201_-199CGG[8]short repeat Uncertain significance 319740 rs567092201 16:55513189-55513190 16:55479277-55479278
24 MMP2 NM_004530.6(MMP2):c.*853A>GSNV Uncertain significance 319783 rs539550309 16:55540207-55540207 16:55506295-55506295
25 MMP2 NM_004530.6(MMP2):c.*498A>GSNV Uncertain significance 319779 rs886052127 16:55539852-55539852 16:55505940-55505940
26 MMP2 NM_004530.6(MMP2):c.1144G>A (p.Asp382Asn)SNV Uncertain significance 319755 rs555030156 16:55523700-55523700 16:55489788-55489788
27 MMP2 NM_004530.6(MMP2):c.539A>T (p.Asp180Val)SNV Uncertain significance 374345 rs1057518712 16:55519220-55519220 16:55485308-55485308
28 MMP2 NM_004530.6(MMP2):c.377A>G (p.Tyr126Cys)SNV Uncertain significance 690375 16:55517044-55517044 16:55483132-55483132
29 MMP2 NM_004530.6(MMP2):c.*250C>TSNV Uncertain significance 888372 16:55539604-55539604 16:55505692-55505692
30 MMP2 NM_004530.6(MMP2):c.*277G>ASNV Uncertain significance 888373 16:55539631-55539631 16:55505719-55505719
31 MMP2 NM_004530.6(MMP2):c.*505T>GSNV Uncertain significance 885266 16:55539859-55539859 16:55505947-55505947
32 MMP2 NM_004530.6(MMP2):c.*642T>CSNV Uncertain significance 885268 16:55539996-55539996 16:55506084-55506084
33 MMP2 NM_004530.6(MMP2):c.*799G>ASNV Uncertain significance 886161 16:55540153-55540153 16:55506241-55506241
34 MMP2 NM_004530.6(MMP2):c.*1012T>ASNV Uncertain significance 886162 16:55540366-55540366 16:55506454-55506454
35 MMP2 NM_004530.6(MMP2):c.*1029G>ASNV Uncertain significance 886163 16:55540383-55540383 16:55506471-55506471
36 MMP2 NM_004530.6(MMP2):c.*1048C>TSNV Uncertain significance 886164 16:55540402-55540402 16:55506490-55506490
37 MMP2 NM_004530.6(MMP2):c.*1204A>GSNV Uncertain significance 887176 16:55540558-55540558 16:55506646-55506646
38 MMP2 NM_004530.6(MMP2):c.153+12C>TSNV Uncertain significance 885134 16:55513556-55513556 16:55479644-55479644
39 MMP2 NM_004530.6(MMP2):c.-147T>ASNV Uncertain significance 886975 16:55513245-55513245 16:55479333-55479333
40 MMP2 NM_004530.6(MMP2):c.38C>G (p.Pro13Arg)SNV Uncertain significance 888242 16:55513429-55513429 16:55479517-55479517
41 MMP2 NM_004530.6(MMP2):c.115G>A (p.Gly39Ser)SNV Uncertain significance 888243 16:55513506-55513506 16:55479594-55479594
42 MMP2 NM_004530.6(MMP2):c.306C>T (p.Cys102=)SNV Uncertain significance 885135 16:55516973-55516973 16:55483061-55483061
43 MMP2 NM_004530.6(MMP2):c.344G>T (p.Arg115Leu)SNV Uncertain significance 885136 16:55517011-55517011 16:55483099-55483099
44 MMP2 NM_004530.6(MMP2):c.474G>A (p.Arg158=)SNV Uncertain significance 885137 16:55518021-55518021 16:55484109-55484109
45 MMP2 NM_004530.6(MMP2):c.813C>T (p.Tyr271=)SNV Uncertain significance 886041 16:55519670-55519670 16:55485758-55485758
46 MMP2 NM_004530.6(MMP2):c.887G>A (p.Arg296His)SNV Uncertain significance 886042 16:55522509-55522509 16:55488597-55488597
47 MMP2 NM_004530.6(MMP2):c.890T>A (p.Phe297Tyr)SNV Uncertain significance 886043 16:55522512-55522512 16:55488600-55488600
48 MMP2 NM_004530.6(MMP2):c.920C>T (p.Thr307Ile)SNV Uncertain significance 886044 16:55522542-55522542 16:55488630-55488630
49 MMP2 NM_004530.6(MMP2):c.969C>T (p.Tyr323=)SNV Uncertain significance 887036 16:55522591-55522591 16:55488679-55488679
50 MMP2 NM_004530.6(MMP2):c.1276A>C (p.Thr426Pro)SNV Uncertain significance 888305 16:55525808-55525808 16:55491896-55491896

Expression for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Search GEO for disease gene expression data for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum.

Pathways for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Pathways related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.96 MMP2 MMP14
2 11.54 MMP2 MMP14
3 11.35 MMP2 MMP14
4
Show member pathways
11.15 MMP2 MMP14
5 10.78 MMP2 MMP14
6 10.41 MMP2 MMP14

GO Terms for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

Cellular components related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular matrix GO:0031012 8.62 MMP2 MMP14

Biological processes related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 angiogenesis GO:0001525 9.4 MMP2 MMP14
2 extracellular matrix organization GO:0030198 9.37 MMP2 MMP14
3 response to hypoxia GO:0001666 9.32 MMP2 MMP14
4 extracellular matrix disassembly GO:0022617 9.26 MMP2 MMP14
5 collagen catabolic process GO:0030574 9.16 MMP2 MMP14
6 endodermal cell differentiation GO:0035987 8.96 MMP2 MMP14
7 tissue remodeling GO:0048771 8.62 MMP2 MMP14

Molecular functions related to Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 metallopeptidase activity GO:0008237 9.16 MMP2 MMP14
2 metalloendopeptidase activity GO:0004222 8.96 MMP2 MMP14
3 endopeptidase activity GO:0004175 8.62 MMP2 MMP14

Sources for Multicentric Osteolysis-Nodulosis-Arthropathy Spectrum

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....